Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2025-12-24 @ 2:59 PM
NCT ID:
NCT02724059
Eligibility Criteria:
Inclusion Criteria:
* Hilar/mediastinal lymph nodes with a short axis more than 1 cm on thoracic CT scan and/or PET-CT suspicious for malignancy with or without known lung malignancy.
* Hilar and/or mediastinal lymph nodes positive on PET/CT scan without regarding the diameter suspicious for malignancy.
* Recurrence or restaging of NSCLC after chemotherapy or radiation.
* Diagnosis of both benign and malignant mediastinal lesions.
Exclusion Criteria:
* Cardiovascular instability.
* Lack of patient cooperation, e.g. intractable cough, inability to remain motionless or altered consciousness.
* Bleeding diathesis (activated partial thromboplastin time (APTT) ratio or international normalized ratio (INR) \<1.3 or platelet count of \<50000 per mm3).
* Border line respiratory failure and patient on mechanical ventilation.
* Severe chronic obstructive pulmonary disease (COPD) (FEV1\<1 liter or \<35% predicted).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02724059
Study Brief:
Protocol Section:
NCT02724059